Publications by authors named "Mark Geraci"

Claim this Profile
C
Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis.
Nawar Al Nasrallah, Bowa Lee, Benjamin M Wiese, Marie N Karam, Elizabeth A Mickler, Mark W Geraci

Oncotarget· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
Jason Hong, Lejla Medzikovic, Wasila Sun, Brenda Wong, Grégoire Ruffenach, Mark W Geraci

Circulation· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette Smoke and Decreased DNA Repair by Xeroderma Pigmentosum Group C Use a Double Hit Mechanism for Epithelial Cell Lung Carcinogenesis.
Nawar Al Nasrallah, Bowa Lee, Benjamin M Wiese, Marie N Karam, Elizabeth A Mickler, Mark W Geraci

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.
Sonia M Thomas, Robert A Harrington, Clyde W Yancy, Diane Nugent, Serpil Erzurum, Mark Geraci

NEJM Evid· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
Jason Hong, Lejla Medzikovic, Wasila Sun, Brenda Wong, Grégoire Ruffenach, Mark W Geraci

Circulation· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial.
Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, Jeffrey S Berger, Harmony R Reynolds, Mark W Geraci

Lancet Diabetes Endocrinol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Business of Medicine: Developing Leaders in Academic Medicine and Learning Health Systems.
Sylk Sotto-Santiago, Chemen Neal, Darren Caudill, Amanda Gist, Susannah Eastwick, Mark W Geraci

J Healthc Leadersh· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity supplements: An underutilized opportunity to improve the diversity of the health sciences research workforce.
Doris Rubio, Noble Maseru, Laura Miller, Mark Geraci, Greg Cooper

J Clin Transl Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
Scott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, Alexander Peikert, Orly Vardeny, Mark W Geraci

Circulation· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative genetic and genomic networks identify microRNA associated with COPD and ILD.
Ana B Pavel, Carly Garrison, Lingqi Luo, Gang Liu, Daniel Taub, Mark W Geraci

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
Jeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, Michelle N Gong, Harmony R Reynolds, Mark W Geraci

JAMA Netw Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Tracy Y Wang, Abdus S Wahed, Alison Morris, Lisa Baumann Kreuziger, John G Quigley, Mark W Geraci

Ann Intern Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Multiomics to Dissect the Lung Transcriptional Landscape of Pulmonary Arterial Hypertension.
Jason Hong, Brenda Wong, Christopher J Rhodes, Zeyneb Kurt, Tae-Hwi Schwantes-An, Mark W Geraci

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.
Anna R Hemnes, Jane A Leopold, Milena K Radeva, Gerald J Beck, Aiden Abidov, Mark W Geraci

J Am Coll Cardiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Coverage Whole Genome Sequencing Using Laser Capture Microscopy with Combined Digital Droplet PCR: An Effective Tool to Study Copy Number and Kras Mutations in Early Lung Adenocarcinoma Development.
Elizabeth A Mickler, Huaxin Zhou, Tzu L Phang, Mark W Geraci, Robert S Stearman

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provider and clinical setting characteristics associated with tobacco pharmacotherapy dispensed in the Veterans Health Administration.
Amanda C Blok, Rosalinda V Ignacio, Mark C Geraci, Hyungjin Myra Kim, Paul G Barnett

Tob Induc Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voices for Social Justice and Against Racism: An AAIM Perspective.
Patricia W Finn, Dale Abel, Alpesh Amin, Mark E Anderson, John M Carethers, Mark W Geraci

Am J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-Regulation of the Long Noncoding RNA X-Inactive-Specific Transcript and the Sex Bias in Pulmonary Arterial Hypertension.
Shanshan Qin, Dan Predescu, Brandon Carman, Priyam Patel, Jiwang Chen, Mark Geraci

Am J Pathol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.
William M Oldham, Anna R Hemnes, Micheala A Aldred, John Barnard, Evan L Brittain, Mark W Geraci

J Am Coll Cardiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asking the Right Questions About Secondhand Smoke.
Jonathan D Klein, Margaret E Chamberlin, Elizabeth A Kress, Mark W Geraci, Susan Rosenblatt

Nicotine Tob Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic profiles in pulmonary arterial hypertension associate with disease severity and identify novel candidate genes.
Casey E Romanoski, Xinshuai Qi, Shreya Sangam, Rebecca R Vanderpool, Robert S Stearman, Mark W Geraci

Pulm Circ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic modifications in developmental cardiopulmonary adaptations to chronic hypoxia using a murine model of simulated high-altitude exposure.
Sheila Krishnan, Robert S Stearman, Lily Zeng, Amanda Fisher, Elizabeth A Mickler, Mark W Geraci

Am J Physiol Lung Cell Mol Physiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration.
Sherrie L Aspinall, Xinhua Zhao, Mark C Geraci, Chester B Good, Francesca E Cunningham

Cancer Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.
Robert L Keith, Patrick J Blatchford, Daniel T Merrick, Paul A Bunn, Brandi Bagwell, Mark W Geraci

Cancer Prev Res (Phila)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation.
Lorenzo Zaffiri, Rupal J Shah, Robert S Stearman, Katia Rothhaar, Amir M Emtiazjoo, Mark W Geraci

Transpl Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis